28751-70-4 Usage
Uses
Used in Pharmaceutical Industry:
5-Chloro-1H-indazole-3-carboxamide is used as a chemical intermediate for the synthesis of various bioactive compounds and pharmaceuticals. Its unique structure and properties make it a valuable component in the development of new drugs and therapeutics.
Used in Chemical Research:
In the field of chemical research, 5-Chloro-1H-indazole-3-carboxamide serves as a key compound for studying the properties and reactions of indazole derivatives. This helps in understanding their potential applications and furthering the development of novel chemical entities.
Used in Drug Development:
5-Chloro-1H-indazole-3-carboxamide is employed in the development of new drugs and therapeutics, leveraging its structural and chemical properties to create innovative pharmaceutical agents. Its potential applications in this area highlight its importance in advancing medical treatments and improving patient outcomes.
Used in Controlled Laboratory Environments:
Due to its potential health hazards, 5-Chloro-1H-indazole-3-carboxamide is used exclusively by trained professionals in controlled laboratory environments. This ensures the safe handling and manipulation of the compound, minimizing risks associated with its use and promoting responsible research practices.
Check Digit Verification of cas no
The CAS Registry Mumber 28751-70-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,8,7,5 and 1 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 28751-70:
(7*2)+(6*8)+(5*7)+(4*5)+(3*1)+(2*7)+(1*0)=134
134 % 10 = 4
So 28751-70-4 is a valid CAS Registry Number.
28751-70-4Relevant academic research and scientific papers
NOVEL INDAZOLE COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF
-
Page/Page column 17; 18, (2015/02/25)
The patent discloses novel indazole compounds of general formula1 and analogues thereof, use thereof for the treatment of diabetes, diabetic complications, cardiovascular dysfuntion or related diseases, pharmaceutical compositions comprising them and processes for their preparation.
